Victoria, Canada, November 12, 2019 – Shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) lost -0.58% to $5.11. The stock grabbed the investor’s attention and traded 1.003M shares as compared to its average daily volume of 954.78K shares.
Aurinia Pharmaceuticals (AUPH) posted revenues of $0.03M for the quarter ended June 2019, missing the Zacks Consensus Estimate by 45.28%. This compares to year-ago revenues of $0.29M. The company has topped consensus revenue estimates just once over the last four quarters. The company came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
AUPH has a market value of $483.11M while its EPS was booked as $-0.70 in the last 12 months. The stock has 94.17M shares outstanding. Analyst recommendation for this stock stands at 1.70.
I am the driving force behind Digital Market News with a vision to broaden the company’s readership throughout 2016. I am an editor and reporter of “Healthcare” category.
Address: 1091 Stratford Park, St Meinrad, IN 47577, USA
Phone: (+1) 812-836-1428
Latest posts by Ron Barnett (see all)
- An Eye on Financial Results: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) - November 12, 2019
- Brief Overview on Company’s Performance: Athersys Inc. (NASDAQ: ATHX) - July 29, 2019
- Featured Earnings Report: Aduro BioTech Inc. (NASDAQ: ADRO) - July 26, 2019